The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Investigational New Drug Contract Development and Manufacturing Market Research Report 2024

Global Investigational New Drug Contract Development and Manufacturing Market Research Report 2024

Publishing Date : Feb, 2022

License Type :
 

Report Code : 1674388

No of Pages : 94

Synopsis
Market Analysis and Insights: Global Investigational New Drug Contract Development and Manufacturing Market
The global Investigational New Drug Contract Development and Manufacturing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Contract Development accounting for % of the Investigational New Drug Contract Development and Manufacturing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Investigational New Drug Contract Development and Manufacturing market size is valued at US$ million in 2021, while the North America and Europe Investigational New Drug Contract Development and Manufacturing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Investigational New Drug Contract Development and Manufacturing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Investigational New Drug Contract Development and Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Investigational New Drug Contract Development and Manufacturing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Investigational New Drug Contract Development and Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Investigational New Drug Contract Development and Manufacturing market.
Global Investigational New Drug Contract Development and Manufacturing Scope and Market Size
Investigational New Drug Contract Development and Manufacturing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Investigational New Drug Contract Development and Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Contract Development
Contract Manufacturing
Segment by Application
Pharmaceutical
Biotechnology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Covance Inc.
Charles River Laboratories Inc.
Cambrex Corporation
IQVIA Holdings Inc.
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Contract Development
1.2.3 Contract Manufacturing
1.3 Market by Application
1.3.1 Global Investigational New Drug Contract Development and Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Investigational New Drug Contract Development and Manufacturing Market Perspective (2017-2028)
2.2 Investigational New Drug Contract Development and Manufacturing Growth Trends by Region
2.2.1 Investigational New Drug Contract Development and Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Investigational New Drug Contract Development and Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Investigational New Drug Contract Development and Manufacturing Market Dynamics
2.3.1 Investigational New Drug Contract Development and Manufacturing Industry Trends
2.3.2 Investigational New Drug Contract Development and Manufacturing Market Drivers
2.3.3 Investigational New Drug Contract Development and Manufacturing Market Challenges
2.3.4 Investigational New Drug Contract Development and Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Investigational New Drug Contract Development and Manufacturing Players by Revenue
3.1.1 Global Top Investigational New Drug Contract Development and Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Investigational New Drug Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Investigational New Drug Contract Development and Manufacturing Revenue
3.4 Global Investigational New Drug Contract Development and Manufacturing Market Concentration Ratio
3.4.1 Global Investigational New Drug Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Investigational New Drug Contract Development and Manufacturing Revenue in 2021
3.5 Investigational New Drug Contract Development and Manufacturing Key Players Head office and Area Served
3.6 Key Players Investigational New Drug Contract Development and Manufacturing Product Solution and Service
3.7 Date of Enter into Investigational New Drug Contract Development and Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Investigational New Drug Contract Development and Manufacturing Breakdown Data by Type
4.1 Global Investigational New Drug Contract Development and Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Type (2023-2028)
5 Investigational New Drug Contract Development and Manufacturing Breakdown Data by Application
5.1 Global Investigational New Drug Contract Development and Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
6.2 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
6.3 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
7.2 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
7.3 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
8.3 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
9.2 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
9.3 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
10.3 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Covance Inc.
11.1.1 Covance Inc. Company Detail
11.1.2 Covance Inc. Business Overview
11.1.3 Covance Inc. Investigational New Drug Contract Development and Manufacturing Introduction
11.1.4 Covance Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.1.5 Covance Inc. Recent Development
11.2 Charles River Laboratories Inc.
11.2.1 Charles River Laboratories Inc. Company Detail
11.2.2 Charles River Laboratories Inc. Business Overview
11.2.3 Charles River Laboratories Inc. Investigational New Drug Contract Development and Manufacturing Introduction
11.2.4 Charles River Laboratories Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.2.5 Charles River Laboratories Inc. Recent Development
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Company Detail
11.3.2 Cambrex Corporation Business Overview
11.3.3 Cambrex Corporation Investigational New Drug Contract Development and Manufacturing Introduction
11.3.4 Cambrex Corporation Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.3.5 Cambrex Corporation Recent Development
11.4 IQVIA Holdings Inc.
11.4.1 IQVIA Holdings Inc. Company Detail
11.4.2 IQVIA Holdings Inc. Business Overview
11.4.3 IQVIA Holdings Inc. Investigational New Drug Contract Development and Manufacturing Introduction
11.4.4 IQVIA Holdings Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.4.5 IQVIA Holdings Inc. Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Detail
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health Investigational New Drug Contract Development and Manufacturing Introduction
11.5.4 Syneos Health Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.5.5 Syneos Health Recent Development
11.6 Lonza
11.6.1 Lonza Company Detail
11.6.2 Lonza Business Overview
11.6.3 Lonza Investigational New Drug Contract Development and Manufacturing Introduction
11.6.4 Lonza Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.6.5 Lonza Recent Development
11.7 Catalent
11.7.1 Catalent Company Detail
11.7.2 Catalent Business Overview
11.7.3 Catalent Investigational New Drug Contract Development and Manufacturing Introduction
11.7.4 Catalent Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.7.5 Catalent Recent Development
11.8 Recipharm AB
11.8.1 Recipharm AB Company Detail
11.8.2 Recipharm AB Business Overview
11.8.3 Recipharm AB Investigational New Drug Contract Development and Manufacturing Introduction
11.8.4 Recipharm AB Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.8.5 Recipharm AB Recent Development
11.9 Siegfried Holding AG
11.9.1 Siegfried Holding AG Company Detail
11.9.2 Siegfried Holding AG Business Overview
11.9.3 Siegfried Holding AG Investigational New Drug Contract Development and Manufacturing Introduction
11.9.4 Siegfried Holding AG Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.9.5 Siegfried Holding AG Recent Development
11.10 Thermo Fisher Scientific Inc.
11.10.1 Thermo Fisher Scientific Inc. Company Detail
11.10.2 Thermo Fisher Scientific Inc. Business Overview
11.10.3 Thermo Fisher Scientific Inc. Investigational New Drug Contract Development and Manufacturing Introduction
11.10.4 Thermo Fisher Scientific Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.10.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Contract Development
Table 3. Key Players of Contract Manufacturing
Table 4. Global Investigational New Drug Contract Development and Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Investigational New Drug Contract Development and Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Investigational New Drug Contract Development and Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Investigational New Drug Contract Development and Manufacturing Market Share by Region (2017-2022)
Table 8. Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Investigational New Drug Contract Development and Manufacturing Market Share by Region (2023-2028)
Table 10. Investigational New Drug Contract Development and Manufacturing Market Trends
Table 11. Investigational New Drug Contract Development and Manufacturing Market Drivers
Table 12. Investigational New Drug Contract Development and Manufacturing Market Challenges
Table 13. Investigational New Drug Contract Development and Manufacturing Market Restraints
Table 14. Global Investigational New Drug Contract Development and Manufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Investigational New Drug Contract Development and Manufacturing Market Share by Players (2017-2022)
Table 16. Global Top Investigational New Drug Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug Contract Development and Manufacturing as of 2021)
Table 17. Ranking of Global Top Investigational New Drug Contract Development and Manufacturing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Investigational New Drug Contract Development and Manufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Investigational New Drug Contract Development and Manufacturing Product Solution and Service
Table 21. Date of Enter into Investigational New Drug Contract Development and Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Investigational New Drug Contract Development and Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Type (2017-2022)
Table 25. Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Type (2023-2028)
Table 27. Global Investigational New Drug Contract Development and Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Application (2017-2022)
Table 29. Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Application (2023-2028)
Table 31. North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 41. Covance Inc. Company Detail
Table 42. Covance Inc. Business Overview
Table 43. Covance Inc. Investigational New Drug Contract Development and Manufacturing Product
Table 44. Covance Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 45. Covance Inc. Recent Development
Table 46. Charles River Laboratories Inc. Company Detail
Table 47. Charles River Laboratories Inc. Business Overview
Table 48. Charles River Laboratories Inc. Investigational New Drug Contract Development and Manufacturing Product
Table 49. Charles River Laboratories Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 50. Charles River Laboratories Inc. Recent Development
Table 51. Cambrex Corporation Company Detail
Table 52. Cambrex Corporation Business Overview
Table 53. Cambrex Corporation Investigational New Drug Contract Development and Manufacturing Product
Table 54. Cambrex Corporation Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 55. Cambrex Corporation Recent Development
Table 56. IQVIA Holdings Inc. Company Detail
Table 57. IQVIA Holdings Inc. Business Overview
Table 58. IQVIA Holdings Inc. Investigational New Drug Contract Development and Manufacturing Product
Table 59. IQVIA Holdings Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 60. IQVIA Holdings Inc. Recent Development
Table 61. Syneos Health Company Detail
Table 62. Syneos Health Business Overview
Table 63. Syneos Health Investigational New Drug Contract Development and Manufacturing Product
Table 64. Syneos Health Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 65. Syneos Health Recent Development
Table 66. Lonza Company Detail
Table 67. Lonza Business Overview
Table 68. Lonza Investigational New Drug Contract Development and Manufacturing Product
Table 69. Lonza Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 70. Lonza Recent Development
Table 71. Catalent Company Detail
Table 72. Catalent Business Overview
Table 73. Catalent Investigational New Drug Contract Development and Manufacturing Product
Table 74. Catalent Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 75. Catalent Recent Development
Table 76. Recipharm AB Company Detail
Table 77. Recipharm AB Business Overview
Table 78. Recipharm AB Investigational New Drug Contract Development and Manufacturing Product
Table 79. Recipharm AB Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 80. Recipharm AB Recent Development
Table 81. Siegfried Holding AG Company Detail
Table 82. Siegfried Holding AG Business Overview
Table 83. Siegfried Holding AG Investigational New Drug Contract Development and Manufacturing Product
Table 84. Siegfried Holding AG Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 85. Siegfried Holding AG Recent Development
Table 86. Thermo Fisher Scientific Inc. Company Detail
Table 87. Thermo Fisher Scientific Inc. Business Overview
Table 88. Thermo Fisher Scientific Inc. Investigational New Drug Contract Development and Manufacturing Product
Table 89. Thermo Fisher Scientific Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022) & (US$ Million)
Table 90. Thermo Fisher Scientific Inc. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Investigational New Drug Contract Development and Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Contract Development Features
Figure 3. Contract Manufacturing Features
Figure 4. Global Investigational New Drug Contract Development and Manufacturing Market Share by Application in 2021 & 2028
Figure 5. Pharmaceutical Case Studies
Figure 6. Biotechnology Case Studies
Figure 7. Others Case Studies
Figure 8. Investigational New Drug Contract Development and Manufacturing Report Years Considered
Figure 9. Global Investigational New Drug Contract Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Investigational New Drug Contract Development and Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Investigational New Drug Contract Development and Manufacturing Market Share by Region: 2021 VS 2028
Figure 12. Global Investigational New Drug Contract Development and Manufacturing Market Share by Players in 2021
Figure 13. Global Top Investigational New Drug Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug Contract Development and Manufacturing as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Investigational New Drug Contract Development and Manufacturing Revenue in 2021
Figure 15. North America Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Investigational New Drug Contract Development and Manufacturing Market Share by Country (2017-2028)
Figure 17. United States Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Investigational New Drug Contract Development and Manufacturing Market Share by Country (2017-2028)
Figure 21. Germany Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Share by Region (2017-2028)
Figure 29. China Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Investigational New Drug Contract Development and Manufacturing Market Share by Country (2017-2028)
Figure 37. Mexico Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Share by Country (2017-2028)
Figure 41. Turkey Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Covance Inc. Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 44. Charles River Laboratories Inc. Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 45. Cambrex Corporation Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 46. IQVIA Holdings Inc. Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 47. Syneos Health Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 48. Lonza Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 49. Catalent Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 50. Recipharm AB Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 51. Siegfried Holding AG Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’